Список литературы

Поставить закладку

Андреева НС, Реброва ОЮ, Зорин НА Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские технологии Оценка и выбор 2012;4:10–24.
Rahimtoola SH Foreword. Curr Probl Cardiol 2009 Mar;34:89.
Земцовский ЭВ, Малев ЭГ, Березовская ГА, Парфенова НН, Реева СВ, Лунева ЕБ, et al. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение Российские рекомендации (I пересмотр). Российский кардиологический журнал 2013;1:1–32.
Carpentier A. Congenital malformations of the mitral valve Surgery for congenital heart defects. W. B. Saunders Philadelphia, 1994, 1994.
Бокерия ЛА, Ким АИ, Абдувохидов БУ, Серов РА, Лашнева АС Хирургическая анатомия митрального клапана у детей раннего возраста. Детские болезни сердца и сосудов 2012 [cited 2018 May 30];37–44.
Белоконь НА, Подзолков ВП Врожденные пороки сердца. Медицина Москва, 1991, 1990, [cited 2021 May 28].Available from: http://padabum.com/d.php?id=40831
Rothenburger M, Rukosujew A, Hammel D, Dorenkamp A, Schmidt C, Schmid C, et al. Mitral valve surgery in patients with poor left ventricular function. Thorac Cardiovasc Surg 2002 Dec;50:351–354.
Bonow RO, Carabello B, De Leon J, Edmunds J, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). Circulation 1998 Nov 3;98:1949–1984.
Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population: The benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002 Oct 2;40:1298–1304.
Земцовский ЭВ, Малев ЭГ, Реева СВ Пролапс митрального клапана: “много шума из ничего” или реальная и нерешенная проблема? Кардиоваскулярная терапия и профилактика 2010 [cited 2021 Sep 7];9:69–74.
Park SM, Park SW, Casaclang-Verzosa G, Ommen SR, Pellikka PA, Miller FA, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial. Am Heart J 2009;157:762.e3-762.e10.
Pederzolli N, Agostini F, Fiorani V, Tappainer E, Nocchi A, Manfredi J, et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med 2009 Mar;10:259–260.
Carpentier A, Adams DH, Filsoufi F Carpentier’s Reconstructive Valve Surgery - 1st Edition. Missouri: Saunders 2010;5–167.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017 Jul 11;70:252–289.
DaCruz EM, Ivy D, Jaggers J Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London, Springer London, 2014. DOI: 10.1007/978-1-4471-4619-3
Boudoulas H, Kolibash AJ, Baker P, King BD, Wooley CF Mitral valve prolapse and the mitral valve prolapse syndrome: A diagnostic classification and pathogenesis of symptoms. Am Heart J 1989;118:796–818.
Чазова ИЕ, Мартынюк ТВ, Валиева ЗС, Азизов ВА, Барбараш ОЛ, Веселова ТН, et al. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал 2020 Mar 30;0:78–122.
Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP Procalcitonin and the Early Diagnosis of Infective Endocarditis. Circulation 2004 Apr 13;109:1707–1710.
Knudsen JB, Fuursted K, Petersen E, Wierup P, Mølgaard H, Poulsen SH, et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 2010 Dec;123:1121–1127.
Kocazeybek B, Küçükoǧlu S, Öner YA Procalcitonin and C-reactive protein in infective endocarditis: Correlation with etiology and prognosis. Chemotherapy 2003;49:76–84.
Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015 Nov 21;36:3075–3123.
Naderi H, Abbara A, Viviano A, Asaria P, Pabari P, Flora R, et al. Re-emphasising the importance of histopathological diagnosis in suspected bacterial endocarditis. Perfusion 2021 Aug 11;026765912110388.
Gupta S, Sakhuja A, McGrath E, Asmar B Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Congenit Heart Dis 2017 Mar 1;12:196–201.
Mahony M, Lean D, Pham L, Horvath R, Suna J, Ward C, et al. Infective Endocarditis in Children in Queensland, Australia: Epidemiology, Clinical Features and Outcome. Pediatr Infect Dis J 2021 Jul 1;40:617–622.
Luca A, Curpan A, Adumitrachioaiei H, Ciobanu I, Dragomirescu C, Manea R, et al. Difficulties in Diagnosis and Therapy of Infective Endocarditis in Children and Adolescents-Cohort Study. Healthc (Basel, Switzerland) 2021 Jun 1;9. DOI: 10.3390/HEALTHCARE9060760
Терещенко СН, Жиров ИВ, Ускач ТМ, Саидова МА, Голицын СП, Гупало ЕМ., et al. Клинические рекомендации Евразийской ассоциации кардиологов (ЕАК)/ национального общества по изучению сердечной недостаточности и заболеваний миокарда (НОИСН) по диагностике и лечению хронической сердечной недостаточности (2020). Евразийский кардиологический журнал 2020 Sep 30;6–76.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017 Sep 21;38:2739–2786.
Nishimura RA, O’Gara PT, Bavaria JE, Brindis RG, Carroll JD, Kavinsky CJ, et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2019 May 28;73:2609–2635.
Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017 Oct 1;52:616– 664.
Gripari P, Muratori M, Fusini L, Tamborini G, Pepi M Three-dimensional echocardiography: Advancements in qualitative and quantitative analyses of mitral valve morphology in mitral valve prolapse. J Cardiovasc Echogr 2014;24:1–9.
Sachdeva R, Valente A, Armstrong A, Cook S, Han B, Lopez L, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society. J Am Soc Echocardiogr 2020 Oct 1;33:e1–e48.
Takahashi K, Mackie AS, Rebeyka IM, Ross DB, Robertson M, Dyck JD, et al. Two-Dimensional Versus Transthoracic Real-Time Three-Dimensional Echocardiography in the Evaluation of the Mechanisms and Sites of Atrioventricular Valve Regurgitation in a Congenital Heart Disease Population. J Am Soc Echocardiogr 2010 Jul;23:726–734.
Cantinotti M, Giordano R, Koestenberger M, Voges I, Santoro G, Franchi E, et al. Echocardiographic examination of mitral valve abnormalities in the paediatric population: current practices. Cardiol Young 2020;30:1–11.
Takahashi K, Mackie A, Rebeyka I, Ross D, Robertson M, Dyck J, et al. Two-dimensional versus transthoracic real-time three-dimensional echocardiography in the evaluation of the mechanisms and sites of atrioventricular valve regurgitation in a congenital heart disease population. J Am Soc Echocardiogr 2010 Jul;23:726–734.
Castello R, Fagan L, Lenzen P, Pearson AC, Labovitz AJ Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 1991 Dec 15;68:1677–1680.
Бокерия ЛА, Голухова ЕЗ, Машина ТВ Трехмерная эхокардиография. НЦ ССХ им. 2002.
Adams DH, Rosenhek R, Falk V Degenerative mitral valve regurgitation: Best practice revolution. Eur Heart J 2010 Aug;31. DOI: 10.1093/eurheartj/ehq222
Agricola E, Oppizzi M, Pisani M, Maisano F, Margonato A Accuracy of real-time 3D echocardiography in the evaluation of functional anatomy of mitral regurgitation. Int J Cardiol 2008 Jul 21;127:342–349.
La Canna G, Arendar I, Maisano F, Monaco F, Collu E, Benussi S, et al. Real-time three- dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am J Cardiol 2011 May 1;107:1365–1374.
Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AK, Levine RA Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. J Am Soc Echocardiogr 1997;10:141–148.
Cantinotti M, Giordano R, Emdin M, Assanta N, Crocetti M, Marotta M, et al. Echocardiographic assessment of pediatric semilunar valve disease. Echocardiography 2017 Sep 1;34:1360–1370.
Ben Zekry S, Nagueh SF, Little SH, Quinones MA, McCulloch ML, Karanbir S, et al. Comparative accuracy of two- and three-dimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: Initial observations. J Am Soc Echocardiogr 2011 Oct;24:1079–1085.
Shernan SK Perioperative transesophageal echocardiographic evaluation of the native mitral valve. Crit Care Med 2007 Aug;35. DOI: 10.1097/01.CCM.0000270248.34274.AB
Carabello BA, Nolan SP, McGuire LB Assessment of preoperative left ventricular function in patients with mitral regurgitation: Value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981;64:1212–1217.
Enriquez-Sarano M, Schaff H V., Orszulak TA, Tajik AJ, Bailey KR, Frye RL Valve repair improves the outcome of surgery for mitral regurgitation: A multivariate analysis. Circulation 1995 Feb 15;91:1022–1028.
Enriquez-Sarano M, Tribouilloy C Quantitation of mitral regurgitation: Rationale, approach, and interpretation in clinical practice. Heart 2002;88. DOI: 10.1136/heart.88.suppl_4.iv1
Simonson JS, Schiller NB Sonospirometry: A new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 1988;11:557–564.
Simpson J, Lopez L, Acar P, Friedberg MK, Khoo NS, Ko HH, et al. Three-dimensional Echocardiography in Congenital Heart Disease: An Expert Consensus Document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017 Jan 1;30:1–27.
Bharucha T, Roman KS, Anderson RH, Vettukattil JJ Impact of Multiplanar Review of Three- Dimensional Echocardiographic Data on Management of Congenital Heart Disease. Ann Thorac Surg 2008 Sep;86:875–881.
Ozturk E, Cansaran Tanidir I, Ayyildiz P, Gokalp S, Candas Kafali H, Sahin M, et al. The role of intraoperative epicardial echocardiography in pediatric cardiac surgery. Echocardiography 2018 Jul 1;35:999–1004.
Choi J, Heo R, Hong GR, Chang HJ, Sung JM, Shin SH, et al. Differential effect of 3-dimensional color doppler echocardiography for the quantifcation of mitral regurgitation according to the severity and characteristics. Circ Cardiovasc Imaging 2014;7:535–544.
Jungwirth B, Mackensen GB Real-time 3-dimensional echocardiography in the operating room. Semin Cardiothorac Vasc Anesth 2008 Dec;12:248–264.
Awasthy N, Girotra S, Dutta N, Azad S, Radhakrishnan S, Iyer K A systematic approach to epicardial echocardiography in pediatric cardiac surgery: An important but underutilized intraoperative tool. Ann Pediatr Cardiol 2021 Apr 1;14:192–200.
Öztürk E, Tanıdır I, Kamalı H, Ayyıldız P, Topel C, Selen Onan I, et al. Comparison of echocardiography and 320-row multidetector computed tomography for the diagnosis of congenital heart disease in children. Rev Port Cardiol 2021 Aug;40:583–590.
Erratum: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) (European Respiratory Journal (2015) 46 (903-975)). Eur Respir J 2015 Dec 1;46:1855–1856.
Guazzi M, Labate V, Vitelli A Letter by Guazzi et al regarding article, comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 2012 Aug 21;126. DOI: 10.1161/CIRCULATIONAHA.111.089698
Применение теста 6-минутной ходьбы для оценки физической выносливости детей и подростков, лечившихся от онкологических заболеваний. Современные проблемы науки и образования (электронный научный журнал) [cited 2021 Sep 3];Available from: https://science-education.ru/ru/article/view?id=28343
Ulrich S, Hildenbrand FF, Treder U, Fischler M, Keusch S, Speich R, et al. Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med 2013 Aug 5;13. DOI: 10.1186/1471-2466-13-49
Oliveira AC, Rodrigues CC, Rolim DS, Souza AA, Nascimento OA, Jardim JR, et al. Six-minute walk test in healthy children: is the leg length important? Pediatr Pulmonol 2013 Sep;48:921–926.
Hassan J, Van Der Net J, Helders PJM, Prakken BJ, Takken T Six-minute walk test in children with chronic conditions. Br J Sports Med 2010 Mar;44:270–274.
Cacau L de AP, de Santana-Filho VJ, Maynard LG, Neto MG, Fernandes M, Carvalho VO Reference values for the six-minute walk test in healthy children and adolescents: A systematic review. Brazilian J Cardiovasc Surg 2016 Sep 1;31:381–388.
Hassan J, van der Net J, Helders PJ, Prakken B.J., Takken T Six-minute walk test in children with chronic conditions. Br J Sports Med 2010 Mar;44:270–274.
Enright PL The six-minute walk test. Respir Care 2003 Aug;48:783–785.
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 Jul 1;166:111–117.
Бубнова МГ, Персиянова-Дуброва АЛ Применение теста с шестиминутной ходьбой в кардиореабилитации. Кардиоваскулярная терапия и профилактика 2020 Jul 13;19:2561.
Grosse-Wortmann L, Kreitz S, Grabitz R, Vazquez-Jimenez J, Messmer B, von Bernuth G, et al. Prevalence of and risk factors for perioperative arrhythmias in neonates and children after cardiopulmonary bypass: continuous holter monitoring before and for three days after surgery. J Cardiothorac Surg 2010 Oct 18;5. DOI: 10.1186/1749-8090-5-85
Sawant A, Bhardwaj A, Srivatsa S, Sridhara S, Prakash M, Kanwar N, et al. Prognostic value of frontal QRS-T angle in predicting survival after primary percutaneous coronary revascularization/coronary artery bypass grafting for ST-elevation myocardial infarction. Indian Heart J 2019 Nov 1;71:481–487.
Houck C, Ramdjan T, Yaksh A, Teuwen C, Lanters E, Bogers A, et al. Intraoperative arrhythmias in children with congenital heart disease: transient, innocent events? Europace 2018 Jul 1;20:e115–e123.
Clark B, Berger J, Berul C, Jonas R, Kaltman J, Lapsa J, et al. Risk Factors for Development of Ectopic Atrial Tachycardia in Post-operative Congenital Heart Disease. Pediatr Cardiol 2018 Mar 1;39:459–465.
Ayyildiz P, Kasar T, Ozturk E, Ozyilmaz I, Tanidir I, Guzeltas A, et al. Evaluation of Permanent or Transient Complete Heart Block after Open Heart Surgery for Congenital Heart Disease. Pacing Clin Electrophysiol 2016 Feb 1;39:160–165.
Mildh L, Hiippala A, Rautiainen P, Pettilä V, Sairanen H, Happonen J Junctional ectopic tachycardia after surgery for congenital heart disease: incidence, risk factors and outcome. Eur J Cardiothorac Surg 2011 Jan;39:75–80.
Ahmed H, VanderPluym C Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1;11. DOI: 10.21037/CDT-20-358
Masarone D, Valente F, Rubino M, Vastarella R, Gravino R, Rea A, et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol 2017 Aug 1;58:303–312.
Das BB, Moskowitz WB, Butler J Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials. Children 2021 Apr 22;8:322.
Shaddy R, George A, Jaecklin T, Lochlainn E, Thakur L, Agrawal R, et al. Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents. Pediatr Cardiol 2018 Mar 1;39:415–436.
Torok R, Li J, Kannankeril P, Atz A, Bishai R, Bolotin E, et al. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc 2018 Feb 1;7. DOI: 10.1161/JAHA.117.007283
Kantor P, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol 2013 Dec;29:1535–1552.
Gong B, Li Z, Yat Wong PC Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth 2015 Dec 1;29:1415–1425.
Burkhardt BEU, Rücker G, Stiller B Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015 Mar 25;2015.
Thorlacius E, Vistnes M, Ojala T, Keski-Nisula J, Molin M, Romlin B, et al. Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data. Pediatr Crit Care Med 2021;22:E402–E409.
Thorlacius EM, Suominen PK, Wåhlander H, Keski-Nisula J, Vistnes M, Ricksten SE, et al. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. Pediatr Crit Care Med 2019 Oct 1;20:947–956.
Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study. Pediatr Crit Care Med 2012 Sep;13:542–548.
Raja SG, Rayen BS Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 2006 Apr;81:1536–1546.
Hussey A, Weintraub R Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. Paediatr Drugs 2016 Apr 1;18:89–99.
Thorlacius EM, Wåhlander H, Ojala T, Ylänen K, Keski-Nisula J, Synnergren M, et al. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial. J Cardiothorac Vasc Anesth 2020 Aug 1;34:2072–2080.
Long Y, Cui D, Kuang X, Hu S, Hu Y, Liu Z Effect of Levosimendan on Ventricular Systolic and Diastolic Functions in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol 2021 Jun 1;77:805–813.
Jothinath K, Balakrishnan S, Raju V, Menon S, Osborn J Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery. Ann Card Anaesth 2021 Apr 1;24:217–223.
Das B Current State of Pediatric Heart Failure. Children 2018 Jun 28;5:88.
Bajcetic M, Uzelac T, Jovanovic I Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients. Curr Med Chem 2014 Aug 13;21:3108–3120.
Colan S Review of the International Society for Heart and Lung Transplantation Practice guidelines for management of heart failure in children. Cardiol Young 2015 Sep 17;25 Suppl 2:154–159.
Del Castillo S, Shaddy R, Kantor P Update on pediatric heart failure. Curr Opin Pediatr 2019 Oct 1;31:598–603.
O’Connor M, Rosenthal D, Shaddy R Outpatient management of pediatric heart failure. Heart Fail Clin 2010 Oct;6:515–529.
Böhm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, et al. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/ valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results fromPARADIGM-HF. Eur Heart J 2017 Apr 14;38:1132–1143.
Ahmed H, VanderPluym C Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1;11. DOI: 10.21037/CDT-20-358
Borer JS, Sharma A Drug therapy for heart valve diseases. Circulation 2015 Sep 15;132:1038– 1045.
Sasayama S, Ohyagi A, Lee JD, Nonogi H, Sakurai T, Wakabayashi A, et al. Effect of the Vasodilator Therapy in Regurgitant Valvular Disease. Jpn Circ J 1982;46:433–441.
Wang A, Grayburn P, Foster JA, McCulloch ML, Badhwar V, Gammie JS, et al. Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel. Am Heart J 2016 Feb 1;172:70–79.
Harris KM, Pastorius CA, Duval S, Harwood E, Henry TD, Carabello BA, et al. Practice Variation Among Cardiovascular Physicians in Management of Patients With Mitral Regurgitation. Am J Cardiol 2009 Jan 15;103:255–261.
Bach DS, Awais M, Gurm HS, Kohnstamm S Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation. J Am Coll Cardiol 2009 Aug 25;54:860–865.
Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery. Pediatr Crit Care Med 2012 Sep;13:542–548.
Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med 2012 Jul 18;38:1198–204.
Boegli YO, Gioanni S, van Steenberghe M, Pouard P Levosimendan in a neonate with severe coarctation of aorta and low cardiac output syndrome. Ann Card Anaesth 2013;16:212–4.
Jentzer J, Ternus B, Eleid V, Rihal C Structural Heart Disease Emergencies. J Intensive Care Med 2021 Sep 1;36:975–988.
Wang H, Luo Q, Li Y, Zhang L, Wu X, Yan F Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery-An Updated Systematic Review and Meta- Analysis. Front Pediatr 2020 Aug 14;8. DOI: 10.3389/FPED.2020.00456
Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, et al. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Crit Care 2019 Dec 30;23. DOI: 10.1186/S13054-019-2704-2
Hummel J, Rücker G, Stiller B Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Cochrane database Syst Rev 2017 Mar 6;3. DOI: 10.1002/14651858.CD011312.PUB2
Abril-Molina A, Gómez-Luque J, Perin F, Esteban-Molina M, Ferreiro-Marzal A, Fernandez- Guerrero C, et al. Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial. Drugs R D 2021 Mar 1;21:79–89.
Malaspinas I, Petak F, Chok L, Perrin A, Martin AL, Beghetti M, et al. Surgical Repair of Mitral Valve Disease in Children: Perioperative Changes in Respiratory Function. J Cardiothorac Vasc Anesth 2016 Oct 1;30:1286–1295.
Díez CC, Khalil F, Schwender H, Dalinghaus M, Jovanovic I, Makowski N, et al. Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European survey. BMJ Paediatr open 2019 Jan 1;3. DOI: 10.1136/BMJPO-2018-000365
Momma K ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs 2006;8:55–69.
Stanford AH, Reyes M, Rios DR, Giesinger RE, Jetton JG, Bischoff AR, et al. Safety, Feasibility, and Impact of Enalapril on Cardiorespiratory Physiology and Health in Preterm Infants with Systemic Hypertension and Left Ventricular Diastolic Dysfunction. J Clin Med 2021 Oct 1;10. DOI: 10.3390/JCM10194519
Mathur K, Hsu DT, Lamour JM, Aydin SI Safety of Enalapril in Infants: Data from the Pediatric Heart Network Infant Single Ventricle Trial. J Pediatr 2020 Dec 1;227:218–223.
Hsu DT, Mital S, Ravishankar C, Margossian R, Li JS, Sleeper LA, et al. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. Am Heart J 2009 Jan;157:37–45.
Kirk R, Dipchand A, Rosenthal D, Addonizio L, Burch M, Chrisant M, et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. [Corrected]. J Heart Lung Transplant 2014;33:888–909.
Butts R, Atz A, BaezHernandez N, Sutcliffe D, Reisch J, Mahony L Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol 2021 Apr 1;42:934–941.
Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier A Beta-blockers for congestive heart failure in children. Cochrane database Syst Rev 2016 Jan 28;2016. DOI: 10.1002/14651858.CD007037.PUB3
Albers S, Meibohm B, Mir T, Läer S Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br J Clin Pharmacol 2008 Apr;65:511– 522.
Varadarajan P, Joshi N, Appel D, Duvvuri L, Pai RG Effect of Beta-Blocker Therapy on Survival in Patients With Severe Mitral Regurgitation and Normal Left Ventricular Ejection Fraction. Am J Cardiol 2008 Sep 1;102:611–615.
Ahmed MI, Aban I, Lloyd SG, Gupta H, Howard G, Inusah S, et al. A randomized controlled phase IIb trial of Beta 1-receptor blockade for chronic degenerative mitral regurgitation. J Am Coll Cardiol 2012 Aug 28;60:833–838.
Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y Beta-blockers for congestive heart failure in children. Cochrane database Syst Rev 2020 Jul 23;7. DOI: 10.1002/14651858.CD007037.PUB4
Shaddy R, Tani L, Gidding S, Pahl E, Orsmond G, Gilbert E, et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 1999 Mar;18:269–274.
Shaddy R, Boucek M, Hsu D, Boucek R, Canter C, Mahony L, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007 Sep 12;298:1171–1179.
Shaddy R, Boucek M, Hsu D, Boucek R, Canter C, Mahony L, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007 Sep 12;298:1171–1179.
Azeka E, Franchini Ramires J, Valler C, Alcides Bocchi E Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 2002 Dec 4;40:2034–2038.
Schranz D, Voelkel N “Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 2016 Apr 1;175:445–455.
Miyamoto S, Stauffer B, Nakano S, Sobus R, Nunley K, Nelson P, et al. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 2014 Jan 1;35:33–41.
Miyamoto S, Stauffer B, Polk J, Medway A, Friedrich M, Haubold K, et al. Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome. J Heart Lung Transplant 2014;33:785–793.
Al-Alaiyan S, Arabia S, Al-Ghamdi N, Pharm B Neonatal Dosage and Practical Guidelines Handbook 2 nd Edition. Al-Alaiyan Riyadh, 2014, King Fahd National library Ministry of Health Kingdom of Saudi Arabia.
Abdel Jalil M, Abdullah N, Alsous M, Saleh M, Abu-Hammour K A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Br J Clin Pharmacol 2020 Jul 1;86:1267–1280.
Ratnapalan S, Griffiths K, Costei AM, Benson L, Koren G Digoxin-carvedilol interactions in children. J Pediatr 2003 May 1;142:572–574.
Moser-Bracher A, Balmer C, Cavigelli A, Satir A, Caduff Good A, Klauwer D Digoxin Toxicity in a Neonate Caused by the Interaction with Carvedilol. Klin Padiatr 2017 Mar 1;229:90–92.
Miller J, Thomas A, Johnson P Use of continuous-infusion loop diuretics in critically ill children. Pharmacotherapy 2014;34:858–867.
Ricci Z, Haiberger R, Pezzella C, Garisto C, Favia I, Cogo P Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: A randomized controlled trial. Crit Care 2015 Jan 7;19. DOI: 10.1186/S13054-014-0724-5
Haiberger R, Favia I, Romagnoli S, Cogo P, Ricci Z Clinical Factors Associated with Dose of Loop Diuretics After Pediatric Cardiac Surgery: Post Hoc Analysis. Pediatr Cardiol 2016 Jun 1;37:913–918.
Senzaki H, Kamiyama M, Masutani S, Ishido H, Taketazu M, Kobayashi T, et al. Efficacy and safety of torasemide in children with heart failure. Arch Dis Child 2008 Sep;93:768–771.
Van Der Vorst MMJ, Kist JE, Van Der Heijden AJ, Burggraaf J Diuretics in pediatrics : current knowledge and future prospects. Paediatr Drugs 2006;8:245–264.
Senzaki H, Kamiyama M, Masutani S, Ishido H, Taketazu M, Kobayashi T, et al. Efficacy and safety of torasemide in children with heart failure. Arch Dis Child 2008 Sep;93:768–771.
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. J Am Dent Assoc 2008;139. DOI: 10.14219/jada.archive.2008.0346
Baumgartner H, Iung B, Otto CM Timing of intervention in asymptomatic patients with valvular heart disease. Eur Heart J 2020 Dec 1;41:4349–4356.
Shah M, Jorde UP Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives. Front Cardiovasc Med 2019 [cited 2021 Aug 20];6:88.
Morningstar J, Nieman A, Wang C, Beck T, Harvey A, Norris R Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition. J Am Heart Assoc 2021 Jul 6;10. DOI: 10.1161/JAHA.121.020919
Barbanti M, Costa G Highlights from the 2020 ACC/AHA guidelines on valvular heart disease. EuroIntervention 2021;16:1303–1305.
Mohananey D, Aljadah M, Smith AAH, Haines JF, Patel S, Villablanca P, et al. The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications. J Cardiothorac Vasc Anesth 2021; DOI: 10.1053/J.JVCA.2021.04.013
Alame AJ, Karatasakis A, Karacsonyi J, Danek BA, Sorajja P, Gössl M, et al. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients with Valvular Heart Disease. J Invasive Cardiol 2017 Sep 1;29:320–326.
Lamm G New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease. Wien Klin Wochenschr 2021;133. DOI: 10.1007/S00508-021-01879-Y
Wada N, Takahashi Y, Ando M, Park IS, Kikuchi T Mitral valve replacement in children under 3 years of age. Japanese J Thorac Cardiovasc Surg 2005;53:545–550.
Yuan H, Wu Z, Lu T, Tang Y, Chen J, Yang Y, et al. Long-term outcomes of mitral valve replacement in patients weighing less than 10 kg. J Cardiothorac Surg 2021 Dec 1;16. DOI: 10.1186/s13019-021-01443-9
Brown JW, Fiore AC, Ruzmetov M, Eltayeb O, Rodefeld MD, Turrentine MW Evolution of mitral valve replacement in children: a 40-year experience. Ann Thorac Surg 2012 Feb;93:626–33; discussion 633.
Masuda M, Kado H, Tatewaki H, Shiokawa Y, Yasui H Late results after mitral valve replacement with bileaflet mechanical prosthesis in children: Evaluation of prosthesis-patient mismatch. Ann Thorac Surg 2004;77:913–917.
Brancaccio G, Trezzi M, Chinali M, Vignaroli W, D’Anna C, Iodice F, et al. Predictors of survival in paediatric mitral valve replacement. Eur J Cardio-Thoracic Surg 2021 Feb 14; DOI: 10.1093/ejcts/ezab078
Ibezim C, Sarvestani AL, Knight JH, Qayum O, Alshami N, Turk E, et al. Outcomes of Mechanical Mitral Valve Replacement in Children. Ann Thorac Surg 2019 Jan 1;107:143–150.
Okamoto T, Nakano T, Goda M, Oda S, Kado H Outcomes of mitral valve replacement with bileaflet mechanical prosthetic valve in children. Gen Thorac Cardiovasc Surg 2020 Jun 1;68:571– 577.
Choi PS, Sleeper LA, Lu M, Upchurch P, Baird C, Emani SM Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses; in : Journal of Thoracic and Cardiovascular Surgery. Mosby Inc., 2021, pp 213-225.e3.
Alghamdi AA, Yanagawa B, Singh SK, Horton A, Al-Radi OO, Caldarone CA Balancing stenosis and regurgitation during mitral valve surgery in pediatric patients. Ann Thorac Surg 2011 Aug;92:680– 4.
Oppido G, Davies B, McMullan DM, Cochrane AD, Cheung MMH, d’Udekem Y, et al. Surgical treatment of congenital mitral valve disease: Midterm results of a repair-oriented policy. J Thorac Cardiovasc Surg 2008;135. DOI: 10.1016/j.jtcvs.2007.09.071
Geoffrion TR, Pirolli TJ, Pruszynski J, Dyer AK, Davies RR, Forbess JM, et al. Mitral Valve Surgery in the First Year of Life. Pediatr Cardiol 2020 Feb 1;41:334–340.
Sawan EB, Brink J, Soquet J, Liava’a M, Brizard CP, Konstantinov IE, et al. The ordeal of left atrioventricular valve replacement in children under 1 year of age; in : Interactive Cardiovascular and Thoracic Surgery. Oxford University Press, 2017, pp 317–322.
Selamet Tierney ES, Pigula FA, Berul CI, Lock JE, del Nido PJ, McElhinney DB Mitral valve replacement in infants and children 5 years of age or younger: Evolution in practice and outcome over three decades with a focus on supra-annular prosthesis implantation. J Thorac Cardiovasc Surg 2008;136. DOI: 10.1016/j.jtcvs.2007.12.076
Mayr B, Vitanova K, Burri M, Lang N, Goppel G, Voss B, et al. Mitral Valve Repair in Children Below Age 10 Years: Trouble or Success?; in : Annals of Thoracic Surgery. Elsevier Inc., 2020, pp 2082–2087.
Elsisy MF, Dearani JA, Ashikhmina E, Krishnan P, Anderson JH, Taggart NW, et al. What Factors Should Be Considered to Improve Outcome of Mechanical Mitral Valve Replacement in Children? World J Pediatr Congenit Hear Surg 2021 May;12:367–374.
Beierlein W, Becker V, Yates R, Tsang V, Elliott M, de Leval M, et al. Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardio- thoracic Surg 2007 May;31:861–866.
Caldarone CA, Raghuveer G, Hills CB, Atkins DL, Burns TL, Behrendt DM, et al. Long-Term Survival After Mitral Valve Replacement in Children Aged <5 Years. Circulation 2001 Sep 18;104:I- 143-I–147.
Ackermann K, Balling G, Eicken A, Günther T, Schreiber C, Hess J Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: Late clinical results of survival and subsequent replacement. J Thorac Cardiovasc Surg 2007 Sep;134:750–756.
Jamart L, Ducharme A, Garceau P, Basmadjian A, Dorval J, Bouchard D, et al. Optimizing Timing of Valve Intervention in Patients With Asymptomatic Severe Valvular Heart Disease. Can J Cardiol 2021 Jul 1;37:1041–1053.
Baird C, Myers P, Marx G, Del Nido P Mitral valve operations at a high-volume pediatric heart center: Evolving techniques and improved survival with mitral valve repair versus replacement; in : Annals of Pediatric Cardiology. Ann Pediatr Cardiol, 2012, pp 13–20.
Stellin G, Padalino MA, Vida VL, Boccuzzo G, Orr E, Biffanti R, et al. Surgical repair of congenital mitral valve malformations in infancy and childhood: A single-center 36-year experience. J Thorac Cardiovasc Surg 2010 Dec;140:1238–1244.
Brancaccio G, Chinali M, Trezzi M, D’Anna C, Esposito C, Rinelli G, et al. Outcome for Conservative Surgery for the Correction of Severe Mitral Valve Regurgitation in Children: A Single- Center Experience. Pediatr Cardiol 2019 Dec 1;40:1663–1669.
Geoffrion TR, Pirolli TJ, Pruszynski J, Dyer AK, Davies RR, Forbess JM, et al. Mitral Valve Surgery in the First Year of Life. Pediatr Cardiol 2020 Feb 1;41:334–340.
Myers PO, Baird CW, Del Nido PJ, Pigula FA, Lang N, Marx GR, et al. Neonatal Mitral Valve Repair in Biventricular Repair, Single Ventricle Palliation, and Secondary Left Ventricular Recruitment: Indications, Techniques, and Mid-Term Outcomes. Front Surg 2015 Nov 10;2:59.
Jiang Z, Mei J, Ding F, Bao C, Zhu J, Tang M, et al. The early and mid-term results of mitral valve repair for mitral regurgitation in children. Surg Today 2014 Oct 11;44:2086–2091.
Hoashi T, Bove EL, Devaney EJ, Hirsch JC, Ohye RG Mitral valve repair for congenital mitral valve stenosis in the pediatric population. Ann Thorac Surg 2010 Jul;90:36–41.
Delmo Walter EM, Hetzer R Repair for Congenital Mitral Valve Stenosis. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2018 Mar 1;21:46–57.
Wood AE, Healy DG, Nolke L, Duff D, Oslizlok P, Walsh K Mitral valve reconstruction in a pediatric population: Late clinical results and predictors of long-term outcome. J Thorac Cardiovasc Surg 2005 Jul;130:66–73.
Beierlein W, Becker V, Yates R, Tsang V, Elliott M, de Leval M, et al. Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardio- thoracic Surg 2007 May;31:861–866.
Shi Y, Xu H, Yan J, Wang Q, Li S, Yi T, et al. The Mid-term Results of Mitral Valve Repair for Isolated Mitral Regurgitation in Infancy and Childhood. Pediatr Cardiol 2017 Dec 1;38:1592–1597.
Baghaei R, Tabib A, Jalili F, Totonchi Z, Mahdavi M, Ghadrdoost B Early and Mid-Term Outcome of Pediatric Congenital Mitral Valve Surgery. Res Cardiovasc Med 2015 Aug;4:e28724.
Kalangos A, Christenson JT, Beghetti M, Cikirikcioglu M, Kamentsidis D, Aggoun Y Mitral Valve Repair for Rheumatic Valve Disease in Children: Midterm Results and Impact of the Use of a Biodegradable Mitral Ring. Ann Thorac Surg 2008 Jul;86:161–169.
del Nido PJ, Baird C Congenital Mitral Valve Stenosis: Anatomic Variants and Surgical Reconstruction. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012;15:69–74.
Fuller S, Spray TL How I Manage Mitral Stenosis in the Neonate and Infant. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009;12:87–93.
Lamberti JJ, Kriett JM Mitral/Systemic Atrioventricular Valve Repair in Congenital Heart Disease. Pediatr Card Surg Annu 2007;10:94–100.
Baird CW, Marx GR, Borisuk M, Emani S, del Nido PJ Review of Congenital Mitral Valve Stenosis: Analysis, Repair Techniques and Outcomes. Cardiovasc Eng Technol 2015 Jun 1;6:167–173.
Chauvaud S Congenital mitral valve surgery: Techniques and results. Curr Opin Cardiol 2006 Mar;21:95–99.
Cikirikcioglu M, Pektok E, Myers PO, Christenson JT, Kalangos A Pediatric mitral valve repair with the novel annuloplasty ring: Kalangos-Bioring®. Asian Cardiovasc Thorac Ann 2008;16:515– 516.
Honjo O, Ishino K, Kawada M, Akagi T, Sano S Midterm outcome of mitral valve repair for congenital mitral regurgitation in infants and children; in : Interactive Cardiovascular and Thoracic Surgery. Interact Cardiovasc Thorac Surg, 2006, pp 589–593.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017 Jul 11;70:252–289.
Feltes TF, Bacha E, Beekman RH, Cheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: A scientific statement from the American Heart Association. Circulation 2011 Jun 7;123:2607–2652.
Рыбка ММ, Хинчагов ДЯ, Мумладзе КВ. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых у новорожденных и детей. Методические рекомендации. НЦССХ им А.Н. Бакулева Москва, 2014.
Park M, Salamat M Park’s Pediatric Cardiology for Practitioners - 7th Edition. Elsevier 2020, [cited 2021 Jun 1].Available from: https://www.elsevier.com/books/parks-pediatric-cardiology-for- practitioners/park/978-0-323-68107-0
Подзолков ВП, Кассирский ГИ Реабилитация больных после хирургического лечения врожденных пороков сердца. НССХХимА.Н. Бакулева Москва, 2015, [cited 2021 Jun 1].Available from: https://science.bakulev.ru/publish_/book/detail.php?ID=8953
Dos L, Rueda Soriano J, Ávila P, Escribano P, Garrido-Lestache Rodríguez-Monte ME, González AE, et al. Comments on the 2020 ESC guidelines for the management of adult congenital heart disease. Rev Española Cardiol (English Ed 2021 May;74:371–377.
Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Circulation 1990;81:1173–1181.
Inciardi RM, Rossi A, Benfari G, Cicoira M Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis. Curr Heart Fail Rep 2018 Apr 1;15:106– 115.
Allen N, O’sullivan K, Jones JM The most influential papers in mitral valve surgery; a bibliometric analysis. J Cardiothorac Surg 2020 Jul 20;15. DOI: 10.1186/s13019-020-01214-y
Phillips HR, Levine FH, Carter JE, Boucher CA, Osbakken MD, Okada RD, et al. Mitral valve replacement for isolated mitral regurgitation: Analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 1981;48:647–654.
Gomez-Doblas JJ, Schor J, Vignola P, Weinberg D, Traad E, Carrillio R, et al. Left ventricular geometry and operative mortality in patients undergoing mitral valve replacement. Clin Cardiol 2001;24:717–722.
Leung DY, Griffin BP, Stewart WJ, Cosgrove DM, Thomas JD, Marwick TH Left ventricular function after valve repair for chronic mitral regurgitation: Predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996 Nov 1;28:1198–1205.
Wisenbaugh T, Skudicky D, Sareli P Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191–197.
Nitsche C, Koschutnik M, Kammerlander A, Hengstenberg C, Mascherbauer J Gender-specific differences in valvular heart disease. Wien Klin Wochenschr 2020 Feb 1;132:61–68.
Chowdhury UK, Kumar AS, Airan B, Mittal D, Subramaniam KG, Prakash R, et al. Mitral valve replacement with and without chordal preservation in a rheumatic population: Serial echocardiographic assessment of left ventricular size and function. Ann Thorac Surg 2005 Jun;79:1926–1933.
Cannegieter SC, Rosendaal FR, Briët E Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–641.
Trzeciak P, Zembala M, Poloński L Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy. Heart Surg Forum 2010 Apr;13. DOI: 10.1532/HSF98.20091097
Ino N, Masutani S, Tanikawa S, Iwamoto Y, Saiki H, Ishido H, et al. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs. J Cardiol 2018 Feb 1;71:187–191.
Jain S, Vaidyanathan B Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Ann Pediatr Cardiol 2010 Jan [cited 2021 Aug 20];3:31–4.
Jain S, Vaidyanathan B Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Ann Pediatr Cardiol 2010 Jan 1;3:31–34.
Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents - PubMed [cited 2021 Aug 20];Available from: https://pubmed.ncbi.nlm.nih.gov/16784079/
Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001 Jan 1;119:220S-227S.
Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: A prospective randomized clinical trial. Circulation 1985;72:1059–1063.
Bradley LM, Midgley FM, Watson DC, Getson PR, Scott LP Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol 1985 Sep 15;56:533–535.
Jobs A, Stiermaier T, Klotz S, Eitel I Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment. Herz 2018 Feb 1;43:26–33.
Harkin M, Shaddix B, Neely S, Peek L, Stephens K, Barker P, et al. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. Am J Health Syst Pharm 2020;77:1018–1025.
Monagle P, Chan A, Goldenberg N, Ichord R, Journeycake J, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e737S-e801S.
Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012;141:e576S-e600S.
Cao H, Wu T, Chen W, Fu J, Xia X, Zhang J The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement. Int J Clin Pharm 2020 Jun 1;42:861–870.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016 Jan 1;37:67–119.